STOCK TITAN
  1. Home
  2. Financials
  3. XGN
  4. EPS (Diluted)

Exagen Inc. (XGN) EPS by Year

XGN

Exagen Inc. lost $0.93 per diluted share in fiscal year 2025. This represents a decrease of 12.0% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $0.81 per diluted share. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Exagen Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.93
YoY -12.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

XGN EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
EPS (Diluted)-$0.81-$0.93-12.0%-$0.83+38.1%-$1.34+51.6%-$2.77-64.9%-$1.68-27.3%-$1.32N/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

XGN EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.13+38.1%-$0.17+15.0%-$0.200.0%-$0.31-10.7%-$0.21-31.2%-$0.20-5.3%-$0.20+35.5%-$0.28+9.7%-$0.16+42.9%-$0.19+56.8%-$0.31+62.7%-$0.31+34.0%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Exagen Inc. financials

Frequently Asked Questions

What was Exagen Inc.'s diluted earnings per share in fiscal year 2025?

Exagen Inc. lost $0.93 per diluted share in fiscal year 2025.

How fast is Exagen Inc.'s diluted earnings per share growing?

Exagen Inc. (XGN) diluted earnings per share fell by 12.0% year over year, from -$0.83 to -$0.93 in fiscal year 2025.

What is Exagen Inc.'s diluted earnings per share over the last twelve months?

Exagen Inc. (XGN) reported a loss of $0.81 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Exagen Inc. (XGN) reported -$0.13 in diluted earnings per share in Q2 2026. This represents an increase of 38.1% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Exagen Inc. (XGN) reported on that line in every period on record.